Category Archives: Treatment Options

Combination Immunotherapy Promising for Treatment of Renal Cell Carcinoma

Novel targeted and immunological therapies may help improve the outlook for patients with renal cell carcinoma (RCC), according to Dr Basma Greef, of the department of oncology at the Cambridge University Hospitals NHS Foundation Trust in the United Kingdom. She and her co-author, professor Tim Eisen, published an article in the British Journal of Cancer suggesting that researchers are introducing a renaissance of immunotherapy in the treatment of RCC.  Read more

U.S. Trends in Treating Small Renal Cancers

A study of the U.S. Surveillance, Epidemiology and End Results (SEER) registry 2001-2009 data shows that surgery continues to be the most common treatment, with nephron-sparing surgery exceeding radical nephrectomy. Dr. william C. Huang, Feinberg School of Medicine, Northwestern University, and his colleagues published their analysis in the July issue of JAMA Surgery.

While nonsurgical management (watchful waiting) is a reasonable treatment strategy for elderly patients or those with limited life

read more

Kidney Cancer Updates from ASCO GU 2016

by Deb Maskens, Kidney Cancer Canada

The American Society of Clinical Oncology (ASCO) held its annual Genitourinary (GU) Cancers Symposium in San Francisco from January 7-9.

The theme of this year’s Symposium was “Patient-Centric Care: Translating Research to Results”. The program included localized and advanced disease, immunotherapy and health care outcomes. The program was bursting with kidney cancer content including 19 presentations, 129 posters and 2 evening ancillary meetings. It was

read more